Hydroxyprogesterone Caproate 500mg/2mL Injection

Hydroxyprogesterone caproate is a long-acting injectable progestogen. It has been used for amenorrhoea, hormone-related abnormal uterine bleeding and selected advanced endometrial cancers in non-pregnant women. Its clinical roles differ from those of natural progesterone.
A clinician gives this oily, long-acting preparation by deep intramuscular injection. The listed 500mg in 2mL is equivalent to 250mg/mL. It is not for intravenous use and cannot replace vaginal progesterone or a subcutaneous hydroxyprogesterone formulation. Injection intervals differ by treatment indication rather than by ampoule size.
It binds progesterone receptors and produces progestogenic effects in hormone-responsive tissues.
Injection-site pain, swelling, itching, nausea and headache may occur; thrombosis and significant allergic reactions are serious concerns.
Tell your doctor about previous blood clots, liver disease, unexplained vaginal bleeding, hormone-sensitive cancer, diabetes or depression. Confirmatory studies did not show a benefit in preventing recurrent preterm birth. Exposure in the womb has also been associated with a possible, unconfirmed long-term cancer risk in the child.
Can produce a sustained progestogenic response in the uterine lining in selected hormonal menstrual disorders. Its role in advanced endometrial cancer is palliative; a tumour response is not guaranteed.
No. Hydroxyprogesterone caproate is a different molecule with different evidence and administration schedules.
No. Confirmatory studies did not demonstrate a benefit for preventing recurrent preterm birth or complications of prematurity in newborns.
No. Pregnancy and non-hormonal causes of bleeding or absent periods need assessment before a hormonal treatment is selected.
No. Route, molecule and indication are different.
One-sided leg swelling, sudden chest pain or unexplained shortness of breath requires emergency assessment.
No. Unexplained genital bleeding needs a diagnosis before hormonal treatment.
No. A schedule cannot be inferred solely from the strength.
No. Oral or vaginal progesterone and hydroxyprogesterone caproate are different medicines. Results for one formulation cannot be transferred to another molecule or route.
Progestogen: a substance with progesterone-like effects. Caproate: an ester producing prolonged action. Confirmatory trial: a study intended to verify clinical benefit., AR: Hydroxyprogesterone / حقن, FR: Hydroxyprogesterone /, PT: Hydroxyprogesterone / injeção, ES: Hydroxyprogesterone / inyección, RU: Hydroxyprogesterone / инъекция, ID: Hydroxyprogesterone / injeksi, VI: Hydroxyprogesterone / thuốc tiêm, MS: Hydroxyprogesterone / suntikan, TL: Hydroxyprogesterone / iniksyon, ZH-SG: Hydroxyprogesterone / 注射剂
International B2B Enquiry
Send a structured B2B enquiry for Hydroxyprogesterone Caproate 500mg/2mL Injection under Women's Health. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Hydroxyprogesterone Caproate 500mg/2mL Injection